Breast cancer patients, going through endocrine treatment may show hot flashes, night sweats and joint symptoms which indicate toward gradual success of the treatment and reduction in estrogen level, that is a key risk factor of breast cancer, British researchers report.
They make comparison of women who reported these symptoms and those who didn’t, at their first visit during a trial evaluating tamoxifen or anastrozole for adjuvant therapy of postmenopausal breast cancer.


